XML 74 R66.htm IDEA: XBRL DOCUMENT
v3.25.2

Agreements - Additional Information (Detail) |  |  |  |  |  |  | 1 Months Ended | 3 Months Ended | 6 Months Ended | 36 Months Ended |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Jul. 11, 2025 USD ($) | Jul. 11, 2024 USD ($) | Jul. 11, 2023 USD ($) | Jan. 24, 2023 | Jul. 11, 2022 USD ($) | Oct. 26, 2012 | Jul. 31, 2023 USD ($) shares | Jul. 31, 2023 SFr / shares | Jun. 30, 2025 USD ($) | Jun. 30, 2024 USD ($) | Dec. 31, 2023 USD ($) | Jun. 30, 2025 USD ($) | Jun. 30, 2025 USD ($) SFr / shares | Jun. 30, 2024 USD ($) | Jul. 11, 2025 USD ($) | Sep. 30, 2024 | Oct. 26, 2023 USD ($) | Jul. 19, 2023
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Research and development expenses |  |  |  |  |  |  |  |  | $ 4,358,000 | $ 2,985,000 |  | $ 8,245,000 |  | $ 5,566,000 |  |  |  |
Asset acquisition equity interests issued or issuable number of shares issued | shares |  |  |  |  |  |  | 1,414,688 |  |  |  |  |  |  |  |  |  |  |
Asset Acquisition Percentage Of Outstanding Ordinary Shares |  |  |  |  |  |  | 11.26% |  |  |  |  |  |  |  |  |  |  |
U.S. Rights for FYCOMPA [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Date on which strategic collaboration is entered into |  |  |  | Jan. 24, 2023 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Payments to acquire productive assets |  |  |  |  |  |  |  |  |  |  |  | 164,200,000 |  |  |  |  |  |
Contingent consideration liability |  |  |  |  |  |  |  |  | 25,000,000 |  |  | $ 25,000,000 | $ 25,000,000 |  |  |  |  |
U.S. Rights for FYCOMPA [Member] | Royalty More Than Ten Million And Less Than Hundred Million [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of royalty on net sales |  |  |  |  |  |  |  |  |  |  |  | 6.00% |  |  |  |  |  |
U.S. Rights for FYCOMPA [Member] | Royalty More Than Ten Million And Less Than Hundred Million [Member] | Royalty Agreement Terms [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of royalty on net sales |  |  |  |  |  |  |  |  |  |  |  | 12.00% |  |  |  |  |  |
U.S. Rights for FYCOMPA [Member] | Royalty More Than Hundred And Twenty Five Million [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of royalty on net sales |  |  |  |  |  |  |  |  |  |  |  | 11.00% |  |  |  |  |  |
Net sales royalty threshold |  |  |  |  |  |  |  |  |  |  |  | $ 125,000,000 |  |  |  |  |  |
U.S. Rights for FYCOMPA [Member] | Royalty More Than Hundred And Twenty Five Million [Member] | Royalty Agreement Terms [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of royalty on net sales |  |  |  |  |  |  |  |  |  |  |  | 22.00% |  |  |  |  |  |
U.S. Rights for FYCOMPA [Member] | Royalty More Than Hundred Million And Less Than Hundred And Twenty Five Million [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of royalty on net sales |  |  |  |  |  |  |  |  |  |  |  | 8.50% |  |  |  |  |  |
U.S. Rights for FYCOMPA [Member] | Royalty More Than Hundred Million And Less Than Hundred And Twenty Five Million [Member] | Royalty Agreement Terms [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of royalty on net sales |  |  |  |  |  |  |  |  |  |  |  | 17.00% |  |  |  |  |  |
AGAMREE [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Payments to acquire productive assets |  |  |  |  |  |  | $ 75,000,000 |  |  |  |  |  |  |  |  |  |  |
Asset acquisition equity interests issued or issuable number of shares issued | shares |  |  |  |  |  |  | 1,414,688 |  |  |  |  |  |  |  |  |  |  |
Asset Acquisition Percentage Of Outstanding Ordinary Shares |  |  |  |  |  |  | 11.26% |  |  |  |  |  |  |  |  |  |  |
Asset Acquisition Investment Share Price | SFr / shares |  |  |  |  |  |  |  |  |  |  |  |  | $ 9.477 |  |  |  |  |
Closing Market Price | SFr / shares |  |  |  |  |  |  |  | SFr 8.25 |  |  |  |  |  |  |  |  |  |
Foreign Currency Exchange Rate, Translation |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1.1537
Collaborative arrangement, milestone payment obligation |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 36,000,000 |
Payment on milestone payment |  |  |  |  |  |  |  |  |  |  | $ 36,000,000 |  |  |  |  |  |  |
Capitalized amortized Cost |  |  |  |  |  |  |  |  |  |  | $ 36,000,000 |  |  |  |  |  |  |
Finite-lived intangible asset, useful life |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 10 years 6 months |  |
AGAMREE [Member] | Royalty Less Than Hundred Million [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of royalty on net sales |  |  |  |  |  |  |  |  |  |  |  | 5.00% |  |  |  |  |  |
AGAMREE [Member] | Royalty More Than Hundred Million And Less Than Two Hundred Million [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of royalty on net sales |  |  |  |  |  |  |  |  |  |  |  | 7.00% |  |  |  |  |  |
AGAMREE [Member] | Royalty More Than Two Hundred Million And Less Than Three Hundred Million [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of royalty on net sales |  |  |  |  |  |  |  |  |  |  |  | 9.00% |  |  |  |  |  |
AGAMREE [Member] | Royalty More Than Three Hundred Million [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of royalty on net sales |  |  |  |  |  |  |  |  |  |  |  | 11.00% |  |  |  |  |  |
AGAMREE [Member] | Royalty Less Than Two Hundred Fifty Million [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of royalty on net sales |  |  |  |  |  |  |  |  |  |  |  | 7.00% |  |  |  |  |  |
AGAMREE [Member] | Royalty More Two Hundred And Fifty Million And Less Than Five Hundred Million [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of royalty on net sales |  |  |  |  |  |  |  |  |  |  |  | 8.50% |  |  |  |  |  |
AGAMREE [Member] | Royalty More Than Five Hundred Million And Less Than Seven Hundred Fifty Million [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of royalty on net sales |  |  |  |  |  |  |  |  |  |  |  | 10.00% |  |  |  |  |  |
AGAMREE [Member] | Royalty More Seven Hundred And Fifty Million And Less Than One Billion [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of royalty on net sales |  |  |  |  |  |  |  |  |  |  |  | 12.00% |  |  |  |  |  |
AGAMREE [Member] | Royalty More Than One Billion And Less Than Two Billion [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of royalty on net sales |  |  |  |  |  |  |  |  |  |  |  | 13.00% |  |  |  |  |  |
AGAMREE [Member] | Royalty More Than Two Billion [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of royalty on net sales |  |  |  |  |  |  |  |  |  |  |  | 15.00% |  |  |  |  |  |
AGAMREE [Member] | Royalty For Santhera Sales Based Milestones [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net sales based milestone to royalty threshold |  |  |  |  |  |  |  |  |  |  |  | $ 105,000,000 |  |  |  |  |  |
Net sales based milestone upon achievement of revenues |  |  |  |  |  |  |  |  |  |  |  | 12,500,000 |  |  |  |  |  |
Revenue milestones |  |  |  |  |  |  |  |  |  |  |  | $ 100,000,000 |  |  |  |  |  |
AGAMREE [Member] | Royalty For Additional Indications And Milestones Of Up To Fifty Million More [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of royalty payable to sales based milestone |  |  |  |  |  |  |  |  |  |  |  | 11.00% |  |  |  |  |  |
AGAMREE [Member] | Royalty For Additional Indications And Milestones [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Contingent consideration liability |  |  |  |  |  |  |  |  | $ 50,000,000 |  |  | $ 50,000,000 | $ 50,000,000 |  |  |  |  |
Minimum [Member] | U.S. Rights for FYCOMPA [Member] | Royalty More Than Ten Million And Less Than Hundred Million [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net sales royalty threshold |  |  |  |  |  |  |  |  |  |  |  | 10,000,000 |  |  |  |  |  |
Minimum [Member] | U.S. Rights for FYCOMPA [Member] | Royalty More Than Ten Million And Less Than Hundred Million [Member] | Royalty Agreement Terms [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net sales royalty threshold |  |  |  |  |  |  |  |  |  |  |  | 10,000,000 |  |  |  |  |  |
Minimum [Member] | U.S. Rights for FYCOMPA [Member] | Royalty More Than Hundred And Twenty Five Million [Member] | Royalty Agreement Terms [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net sales royalty threshold |  |  |  |  |  |  |  |  |  |  |  | 125,000,000 |  |  |  |  |  |
Minimum [Member] | U.S. Rights for FYCOMPA [Member] | Royalty More Than Hundred Million And Less Than Hundred And Twenty Five Million [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net sales royalty threshold |  |  |  |  |  |  |  |  |  |  |  | 100,000,000 |  |  |  |  |  |
Minimum [Member] | U.S. Rights for FYCOMPA [Member] | Royalty More Than Hundred Million And Less Than Hundred And Twenty Five Million [Member] | Royalty Agreement Terms [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net sales royalty threshold |  |  |  |  |  |  |  |  |  |  |  | 100,000,000 |  |  |  |  |  |
Minimum [Member] | AGAMREE [Member] | Royalty More Than Hundred Million And Less Than Two Hundred Million [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net sales royalty threshold |  |  |  |  |  |  |  |  |  |  |  | 100,000,000 |  |  |  |  |  |
Minimum [Member] | AGAMREE [Member] | Royalty More Than Two Hundred Million And Less Than Three Hundred Million [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net sales royalty threshold |  |  |  |  |  |  |  |  |  |  |  | 200,000,000 |  |  |  |  |  |
Minimum [Member] | AGAMREE [Member] | Royalty More Than Three Hundred Million [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net sales royalty threshold |  |  |  |  |  |  |  |  |  |  |  | 300,000,000 |  |  |  |  |  |
Minimum [Member] | AGAMREE [Member] | Royalty More Two Hundred And Fifty Million And Less Than Five Hundred Million [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net sales royalty threshold |  |  |  |  |  |  |  |  |  |  |  | 250,000,000 |  |  |  |  |  |
Minimum [Member] | AGAMREE [Member] | Royalty More Than Five Hundred Million And Less Than Seven Hundred Fifty Million [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net sales royalty threshold |  |  |  |  |  |  |  |  |  |  |  | 500,000,000 |  |  |  |  |  |
Minimum [Member] | AGAMREE [Member] | Royalty More Seven Hundred And Fifty Million And Less Than One Billion [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net sales royalty threshold |  |  |  |  |  |  |  |  |  |  |  | 750,000,000 |  |  |  |  |  |
Minimum [Member] | AGAMREE [Member] | Royalty More Than One Billion And Less Than Two Billion [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net sales royalty threshold |  |  |  |  |  |  |  |  |  |  |  | 1,000,000,000 |  |  |  |  |  |
Minimum [Member] | AGAMREE [Member] | Royalty More Than Two Billion [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net sales royalty threshold |  |  |  |  |  |  |  |  |  |  |  | 2,000,000,000 |  |  |  |  |  |
Maximum [Member] | U.S. Rights for FYCOMPA [Member] | Royalty More Than Ten Million And Less Than Hundred Million [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net sales royalty threshold |  |  |  |  |  |  |  |  |  |  |  | 100,000,000 |  |  |  |  |  |
Maximum [Member] | U.S. Rights for FYCOMPA [Member] | Royalty More Than Ten Million And Less Than Hundred Million [Member] | Royalty Agreement Terms [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net sales royalty threshold |  |  |  |  |  |  |  |  |  |  |  | 100,000,000 |  |  |  |  |  |
Maximum [Member] | U.S. Rights for FYCOMPA [Member] | Royalty More Than Hundred Million And Less Than Hundred And Twenty Five Million [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net sales royalty threshold |  |  |  |  |  |  |  |  |  |  |  | 125,000 |  |  |  |  |  |
Maximum [Member] | U.S. Rights for FYCOMPA [Member] | Royalty More Than Hundred Million And Less Than Hundred And Twenty Five Million [Member] | Royalty Agreement Terms [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net sales royalty threshold |  |  |  |  |  |  |  |  |  |  |  | 125,000,000 |  |  |  |  |  |
Maximum [Member] | AGAMREE [Member] | Royalty Less Than Hundred Million [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net sales royalty threshold |  |  |  |  |  |  |  |  |  |  |  | 100,000,000 |  |  |  |  |  |
Maximum [Member] | AGAMREE [Member] | Royalty More Than Hundred Million And Less Than Two Hundred Million [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net sales royalty threshold |  |  |  |  |  |  |  |  |  |  |  | 200,000,000 |  |  |  |  |  |
Maximum [Member] | AGAMREE [Member] | Royalty More Than Two Hundred Million And Less Than Three Hundred Million [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net sales royalty threshold |  |  |  |  |  |  |  |  |  |  |  | 300,000,000 |  |  |  |  |  |
Maximum [Member] | AGAMREE [Member] | Royalty Less Than Two Hundred Fifty Million [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net sales royalty threshold |  |  |  |  |  |  |  |  |  |  |  | 250,000,000 |  |  |  |  |  |
Maximum [Member] | AGAMREE [Member] | Royalty More Two Hundred And Fifty Million And Less Than Five Hundred Million [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net sales royalty threshold |  |  |  |  |  |  |  |  |  |  |  | 500,000,000 |  |  |  |  |  |
Maximum [Member] | AGAMREE [Member] | Royalty More Than Five Hundred Million And Less Than Seven Hundred Fifty Million [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net sales royalty threshold |  |  |  |  |  |  |  |  |  |  |  | 750,000,000 |  |  |  |  |  |
Maximum [Member] | AGAMREE [Member] | Royalty More Seven Hundred And Fifty Million And Less Than One Billion [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net sales royalty threshold |  |  |  |  |  |  |  |  |  |  |  | 1,000,000,000 |  |  |  |  |  |
Maximum [Member] | AGAMREE [Member] | Royalty More Than One Billion And Less Than Two Billion [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net sales royalty threshold |  |  |  |  |  |  |  |  |  |  |  | $ 2,000,000,000 |  |  |  |  |  |
License Agreement with BioMarin [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Date on which strategic collaboration is entered into |  |  |  |  |  | Oct. 26, 2012 |  |  |  |  |  |  |  |  |  |  |  |
Percentage of royalty on net sales |  |  |  |  |  |  |  |  |  |  |  | 3.50% |  |  |  |  |  |
Net sales royalty threshold |  |  |  |  |  |  |  |  |  |  |  | $ 100,000,000 |  |  |  |  |  |
License Agreement with BioMarin [Member] | Minimum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Royalty agreement period |  |  |  |  |  |  |  |  |  |  |  | 7 years |  |  |  |  |  |
Percentage of royalty on net sales |  |  |  |  |  |  |  |  |  |  |  | 7.00% |  |  |  |  |  |
License Agreement with BioMarin [Member] | Maximum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of royalty on net sales |  |  |  |  |  |  |  |  |  |  |  | 10.00% |  |  |  |  |  |
License Agreement For RUZURGI [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Date on which strategic collaboration is entered into |  |  |  |  | Jul. 11, 2022 |  |  |  |  |  |  |  |  |  |  |  |  |
Minimum royalty | $ 3,000,000 | $ 3,000,000 | $ 3,000,000 |  | $ 3,000,000 |  |  |  |  |  |  |  |  |  | $ 3,000,000 |  |  |
Up front payment |  |  |  |  | $ 10,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Asset acquisition purchase price consideration |  | $ 10,000,000 | $ 10,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Amount of minimum royalty payable maturity terms not met |  |  |  |  |  |  |  |  |  |  |  | $ 5,000,000 |  |  |  |  |  |
License Agreement For RUZURGI [Member] | Minimum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of minimum royalty payable to net sales |  |  |  |  |  |  |  |  |  |  |  | 1.25% |  |  |  |  |  |
License Agreement For RUZURGI [Member] | Maximum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
License Agreement [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of minimum royalty payable to net sales |  |  |  |  |  |  |  |  |  |  |  | 2.50% |  |  |  |  |  |

X
- Definition Amount of minimum royalty payable maturity terms not met. + References No definition available. + Details
Name: | cprx_AmountOfMinimumRoyaltyPayableMaturityTermsNotMet
Namespace Prefix: | cprx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Asset acquisition equity interests issued or issuable number of shares issued. + References No definition available. + Details
Name: | cprx_AssetAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
Namespace Prefix: | cprx_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Asset acquisition investment share price. + References No definition available. + Details
Name: | cprx_AssetAcquisitionInvestmentSharePrice
Namespace Prefix: | cprx_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Asset acquisition percentage of outstanding ordinary shares. + References No definition available. + Details
Name: | cprx_AssetAcquisitionPercentageOfOutstandingOrdinaryShares
Namespace Prefix: | cprx_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Asset acquisition purchase price consideration. + References No definition available. + Details
Name: | cprx_AssetAcquisitionPurchasePriceConsideration
Namespace Prefix: | cprx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Closing market price. + References No definition available. + Details
Name: | cprx_ClosingMarketPrice
Namespace Prefix: | cprx_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Collaborative arrangement milestone payment obligation. + References No definition available. + Details
Name: | cprx_CollaborativeArrangementMilestonePaymentObligation
Namespace Prefix: | cprx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Contingent Consideration Arrangements Contingent Consideration Liability. + References No definition available. + Details
Name: | cprx_ContingentConsiderationArrangementsContingentConsiderationLiability
Namespace Prefix: | cprx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition License agreement date. + References No definition available. + Details
Name: | cprx_LicenseAgreementDate
Namespace Prefix: | cprx_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition License Agreement [Line Items] + References No definition available. + Details
Name: | cprx_LicenseAgreementLineItems
Namespace Prefix: | cprx_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Minimum royalty. + References No definition available. + Details
Name: | cprx_MinimumRoyalty
Namespace Prefix: | cprx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Net sales based milestone to royalty threshold. + References No definition available. + Details
Name: | cprx_NetSalesBasedMilestoneToRoyaltyThreshold
Namespace Prefix: | cprx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Net sales based milestone upon achievement of revenues. + References No definition available. + Details
Name: | cprx_NetSalesBasedMilestoneUponAchievementOfRevenues
Namespace Prefix: | cprx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Represents the amount used to determine the percentage of royalties for the period from the first commercial sale equal to the minimum percentage of net sales in North America for any calendar year for sales up to the amount, and maximum percentage of net sales in North America in any calendar year in excess of the amount. + References No definition available. + Details
Name: | cprx_NetSalesRoyaltyThreshold
Namespace Prefix: | cprx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Payment on milestone payment. + References No definition available. + Details
Name: | cprx_PaymentOnMilestonePayment
Namespace Prefix: | cprx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Percentage of minimum royalty payable to net sales. + References No definition available. + Details
Name: | cprx_PercentageOfMinimumRoyaltyPayableToNetSales
Namespace Prefix: | cprx_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the percentage applied to net sales to determine the amount payable as part of the agreement. + References No definition available. + Details
Name: | cprx_PercentageOfRoyaltyPayableToNetSales
Namespace Prefix: | cprx_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of royalty payable to sales based milestone. + References No definition available. + Details
Name: | cprx_PercentageOfRoyaltyPayableToSalesBasedMilestone
Namespace Prefix: | cprx_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Revenue milestones. + References No definition available. + Details
Name: | cprx_RevenueMilestones
Namespace Prefix: | cprx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The term of the royalty payments from the first commercial sale of product under the agreement. + References No definition available. + Details
Name: | cprx_RoyaltyAgreementTerm
Namespace Prefix: | cprx_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Up-front payment. + References No definition available. + Details
Name: | cprx_UpFrontPayment
Namespace Prefix: | cprx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 340 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479483/340-40-50-3 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147476148/220-40-50-22 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147476148/220-40-50-22 + Details
Name: | us-gaap_CapitalizedContractCostAmortization
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | us-gaap_FiniteLivedIntangibleAssetUsefulLife
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | instant

X
- Definition Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479424/830-30-S99-1 + Details
Name: | us-gaap_ForeignCurrencyExchangeRateTranslation1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:pureItemType
Balance Type: | na
Period Type: | instant

X
- Definition The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 25 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480060/805-50-25-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 30 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480027/805-50-30-1 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 30 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480027/805-50-30-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 45 -Paragraph 13 -Subparagraph (c) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13 + Details
Name: | us-gaap_PaymentsToAcquireProductiveAssets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 220 -SubTopic 40 -Name Accounting Standards Codification -Section 55 -Paragraph 18 -Publisher FASB -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 220 -SubTopic 40 -Name Accounting Standards Codification -Section 55 -Paragraph 14 -Publisher FASB -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 48 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 985 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 730 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1 Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 912 -SubTopic 730 -Name Accounting Standards Codification -Section 25 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1 + Details
Name: | us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_AssetAcquisitionAxis=cprx_U.s.RightsForFycompaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cprx_RoyaltyThresholdLimitAxis=cprx_RoyaltyMoreThanTenMillionAndLessThanHundredMillionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=us-gaap_RoyaltyAgreementTermsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cprx_RoyaltyThresholdLimitAxis=cprx_RoyaltyMoreThanHundredAndTwentyFiveMillionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cprx_RoyaltyThresholdLimitAxis=cprx_RoyaltyMoreThanHundredMillionAndLessThanHundredAndTwentyFiveMillionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AssetAcquisitionAxis=cprx_AgamreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cprx_RoyaltyThresholdLimitAxis=cprx_RoyaltyLessThanHundredMillionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cprx_RoyaltyThresholdLimitAxis=cprx_RoyaltyMoreThanHundredMillionAndLessThanTwoHundredMillionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cprx_RoyaltyThresholdLimitAxis=cprx_RoyaltyMoreThanTwoHundredMillionAndLessThanThreeHundredMillionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cprx_RoyaltyThresholdLimitAxis=cprx_RoyaltyMoreThanThreeHundredMillionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cprx_RoyaltyThresholdLimitAxis=cprx_RoyaltyLessThanTwoHundredFiftyMillionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cprx_RoyaltyThresholdLimitAxis=cprx_RoyaltyMoreTwoHundredAndFiftyMillionAndLessThanFiveHundredMillionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cprx_RoyaltyThresholdLimitAxis=cprx_RoyaltyMoreThanFiveHundredMillionAndLessThanSevenHundredFiftyMillionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cprx_RoyaltyThresholdLimitAxis=cprx_RoyaltyMoreSevenHundredAndFiftyMillionAndLessThanOneBillionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cprx_RoyaltyThresholdLimitAxis=cprx_RoyaltyMoreThanOneBillionAndLessThanTwoBillionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cprx_RoyaltyThresholdLimitAxis=cprx_RoyaltyMoreThanTwoBillionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cprx_RoyaltyThresholdLimitAxis=cprx_RoyaltyForSantheraSalesBasedMilestonesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cprx_RoyaltyThresholdLimitAxis=cprx_RoyaltyForAdditionalIndicationsAndMilestonesOfUpToFiftyMillionMoreMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cprx_RoyaltyThresholdLimitAxis=cprx_RoyaltyForAdditionalIndicationsAndMilestonesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=cprx_LicenseAgreementWithBioMarinMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=cprx_LicenseAgreementForRuzurgiMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |